Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Thomson Reuters Q3 Adjusted Earnings Climb YoY

Thomson Reuters Q3 Adjusted Earnings Climb YoY

MT newswireMT newswire2026/11/03 11:51
07:51 AM EST, 11/03/2026 (MT Newswires) -- Thomson Reuters (TRI.TO) reported Q3 adjusted earnings of $0.81 per share, increasing from $0.71 in the previous year. Analysts polled by FactSet expected $0.83. Revenue for the three months ended Sept. 30 rose to $1.83 billion from $1.66 billion. Analysts expected $1.83 billion. The company declared a quarterly dividend of $0.655 per share, payable Dec. 10 to shareholders of record as of Nov. 18. Thomson Reuters outlined an updated full-year 2026 outlook for the total company to exclude its global print business. The guidance includes total revenue growth of about 9.5% and organic revenue growth of about 8.5%-9.0%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss